Literature DB >> 15751526

Syncope in a middle aged male due to acute rheumatic fever.

Rajat Mohindra1, H S Pannu, Bishav Mohan, Naveen Kumar, H S Dhooria, Alok Sehgal, G Avasthi.   

Abstract

Rheumatic fever is a multi system disease which occurs following infection with group A beta hemolytic streptococcus. It is commonest in the age group of 5-15 years but can occur in adults also. First degree atrioventricular block is a common manifestation of acute rheumatic fever and is included in the Jones criteria but Wenckebacks phenomena and complete heart block are relatively rare manifestations of rheumatic fever. Syncope occurring in acute rheumatic fever is also infrequently reported. We report the case of a 38-year-old male with rheumatic carditis who had advanced atrioventricular block which resulted in syncope and required a temporary pacemaker insertion.

Entities:  

Mesh:

Year:  2004        PMID: 15751526

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  4 in total

1.  A case of Henoch-Schönlein purpura and rheumatic carditis with complete atrioventricular block.

Authors:  Hasan Güven; Bayram Ozhan; Ali Rahmi Bakiler; Koray Salar; Meral Kozan; Selda Bilgin
Journal:  Eur J Pediatr       Date:  2006-03-14       Impact factor: 3.183

2.  Rhythm and conduction analysis of patients with acute rheumatic fever.

Authors:  Sevket Balli; Mehmet Burhan Oflaz; Ayse Esin Kibar; Ibrahim Ece
Journal:  Pediatr Cardiol       Date:  2012-08-07       Impact factor: 1.655

Review 3.  Adams-Stokes attack as the first symptom of acute rheumatic fever: report of an adolescent case and review of the literature.

Authors:  Nicola Carano; Ilaria Bo; Bertrand Tchana; Erica Vecchione; Silvia Fantoni; Aldo Agnetti
Journal:  Ital J Pediatr       Date:  2012-10-30       Impact factor: 2.638

4.  Follow up in a developing country of patients with complete atrio-ventricular block.

Authors:  J C Tantchou Tchoumi; S Foresti; P Lupo; R Cappato; G Butera
Journal:  Cardiovasc J Afr       Date:  2012-11       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.